Growth Metrics

Erasca (ERAS) Non-Current Assets (2020 - 2026)

Erasca posted quarterly Non-Current Assets of $207.4 million for Q1 2026, up 32.45% year-on-year from $156.6 million in Q1 2025, and up 88.74% on a QoQ basis from $109.9 million in Q4 2025.

Erasca (ERAS) has 7 years of Non-Current Assets data on file, last reported at $207.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets rose 32.45% year-over-year to $207.4 million; the trailing twelve-month figure through Mar 2026 stood at $572.6 million (down 12.83% YoY), and the FY2025 full-year result was $109.9 million, down 43.26% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $207.4 million, up from $109.9 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $207.4 million in Q1 2026 and bottomed at $63.4 million in Q1 2024.
  • The 5-year median for Non-Current Assets is $109.9 million (2025), against an average of $114.9 million.
  • The widest annual swing landed in 2022, when Non-Current Assets soared 384.28%; it then slumped 43.26% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $70.4 million in 2022, then climbed by 5.98% to $74.6 million in 2023, then jumped by 159.62% to $193.7 million in 2024, then plunged by 43.26% to $109.9 million in 2025, then surged by 88.74% to $207.4 million in 2026.
  • The last three Non-Current Assets figures came in at $207.4 million (Q1 2026), $109.9 million (Q4 2025), and $120.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 4.56 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 62,953.78
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 486.60 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 5.83 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 30.30 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.75 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 22.66 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 910.24 Mn
10 Erasca 4.21 Bn 3.97 Bn - 207.45 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 207.45 Mn
Dec 31, 2025 109.92 Mn
Sep 30, 2025 120.48 Mn
Jun 30, 2025 134.73 Mn
Mar 31, 2025 156.63 Mn
Dec 31, 2024 193.73 Mn
Sep 30, 2024 198.72 Mn
Jun 30, 2024 107.74 Mn
Mar 31, 2024 63.40 Mn
Dec 31, 2023 74.62 Mn
Sep 30, 2023 113.44 Mn
Jun 30, 2023 116.81 Mn
Mar 31, 2023 69.66 Mn
Dec 31, 2022 70.41 Mn
Sep 30, 2022 80.68 Mn
Jun 30, 2022 63.40 Mn
Mar 31, 2022 72.10 Mn
Dec 31, 2021 81.40 Mn
Sep 30, 2021 29.64 Mn
Jun 30, 2021 13.09 Mn
Dec 31, 2020 4.84 Mn